The massive stroke suffered by Israeli Prime Minister Ariel Sharon is renewing a longstanding debate about the proper treatment of stroke victims. Sharon, who suffered a minor stroke last month, was treated with the clot-busting drug Clexane. Supporters think the drug should be routinely administered to prevent long-term heart damage. Critics, including many ER docs, often disagree vehemently, pointing out that the treatment has been linked to serious cerebral hemorrhaging--exactly the kind of stroke that Sharon suffered this week.
- see this article from ABC News